Literature DB >> 8831585

Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells.

A Andoh1, Y Fujiyama, K Sumiyoshi, H Sakumoto, T Bamba.   

Abstract

BACKGROUND & AIMS: Decay-accelerating factor (DAF) protects host tissues from the attack of autologous complement activation. In this study, we attempted to define the cytokine regulation of DAF messenger RNA (mRNA) expression in human intestinal epithelial cells.
METHODS: The effects of cytokines on DAF mRNA accumulation were evaluated by Northern blot analysis. The DAF protein expression was analyzed by both immunoprecipitation and immunoblotting.
RESULTS: Interleukin (IL)-4 induced a marked increase in DAF mRNA accumulation in HT-29 cells. In this line, IL-1 beta evoked only weak induction, and IL-6, IL-8, IL-10, and interferon gamma had no effect. The effect of IL-4 was observed in a dose-dependent manner and confirmed at the protein level. The increase in DAF mRNA accumulation reached a maximum at 3-6 hours and then gradually decreased. These effects of IL-4 on DAF mRNA and protein expression were also observed in T84 cells. The mRNA stability studies suggested that IL-4 regulates DAF gene expression mainly at the transcriptional level.
CONCLUSIONS: In human intestinal epithelial cells, IL-4 acts as a potent inducer of DAF mRNA expression, suggesting a cytoprotective role for IL-4 against autologous complement activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831585     DOI: 10.1016/s0016-5085(96)70058-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Regulation of epithelial cell functions by the intestinal milieu.

Authors:  Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Sodium butyrate blocks interferon-gamma (IFN-gamma)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells.

Authors:  K Kitamura; A Andoh; T Inoue; Y Amakata; K Hodohara; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells.

Authors:  A Andoh; Y Fujiyama; K Hata; Y Araki; H Takaya; M Shimada; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 6.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells.

Authors:  J Nasu; M Mizuno; T Uesu; K Takeuchi; T Inaba; S Ohya; M Kawada; K Shimo; H Okada; T Fujita; T Tsuji
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

8.  Neutrophils migrate across intestinal epithelium using beta2 integrin (CD11b/CD18)-independent mechanisms.

Authors:  K M Blake; S O Carrigan; A C Issekutz; A W Stadnyk
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts.

Authors:  Yuhki Yagi; Akira Andoh; Osamu Inatomi; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

10.  Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.

Authors:  M Shioya; A Nishida; Y Yagi; A Ogawa; T Tsujikawa; S Kim-Mitsuyama; A Takayanagi; N Shimizu; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.